At a glance
ClinicalIndex Comparison RecordN/ACompleted· 121 enrolled
Drug / intervention
CRTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese Patients With Chronic Heart Failure
In Brief
An observational study evaluating CRT for Chronic Heart Failure. Completed, enrolled 121 participants across 14 sites.
Detailed Summary
The purpose of this clinical study is to observe the safety and efficacy of the multi-vector left ventricular (LV) lead in Chinese patients that are indicated for Cardiac Resynchronization Therapy (CRT).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Heart Failure
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedFeb 2015
Primary CompletionOct 2016
Study CompletionMar 2017
TodayJul 2026
First PostedFeb 20, 2015
Enrollment StartDec 1, 2014
Primary CompletionOct 1, 2016
Study CompletionMar 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.4 years ago
Interventions
CRTdevice
The study will include the Quartet™ family of left heart leads or any newer St. Jude Medical quadripolar CRT systems, including CRT-P systems, that China Food and Drug Administration (CFDA) might approve in the future